HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PSMD14
proteasome 26S subunit, non-ATPase 14
Chromosome 2 · 2q24.2
NCBI Gene: 10213Ensembl: ENSG00000115233.13HGNC: HGNC:16889UniProt: A0A140VKF2
241PubMed Papers
20Diseases
5Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
DNA RepairHomologous RecombinationHub GeneProteaseTransporter
RESEARCH IMPACT
Trending
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
proteasome complexproteasome regulatory particle, lid subcomplexendopeptidase activator activityK63-linked deubiquitinase activitymultiple myelomaneoplasmMantle cell lymphomaneurodegenerative disease
✦AI Summary

PSMD14 is a metalloprotease component of the 26S proteasome that specifically cleaves K63-linked polyubiquitin chains and serves multiple cellular functions beyond protein degradation 1. As a deubiquitinase, PSMD14 regulates DNA damage repair by promoting both non-homologous end joining and homologous recombination pathways through K63-linked polyubiquitin cleavage 1. The protein also controls macroautophagy by ensuring proper Golgi-to-ER retrograde transport through deubiquitination of K63-linked ubiquitin chains 2. Beyond its proteasomal role, PSMD14 functions as an epigenetic regulator, acting as a histone H2AK119 deubiquitinase that facilitates NSD2-directed H3K36 dimethylation and forms a positive feedback loop with RELA in myeloma pathogenesis 3. In cancer contexts, PSMD14 promotes tumor progression through multiple mechanisms: stabilizing metabolic enzymes like PKM2 and SLC7A11 45, enhancing lipid synthesis via LDHA stabilization and histone lactylation 6, and facilitating alternative splicing through SF3B4 stabilization 7. High PSMD14 expression correlates with poor prognosis across multiple cancer types, making it an attractive therapeutic target 8. The protein's diverse functions span from maintaining cellular homeostasis to driving oncogenic processes, highlighting its critical role in both normal physiology and disease pathogenesis.

Sources cited
1
PSMD14 is a metalloprotease that cleaves K63-linked polyubiquitin chains and regulates DNA damage repair pathways
PMID: 22909820
2
PSMD14 regulates macroautophagy through deubiquitinating activity on K63-linked ubiquitin chains in Golgi-ER transport
PMID: 32210007
3
PSMD14 acts as histone H2AK119 deubiquitinase and forms PSMD14/NSD2-RELA feedback loop in myeloma
PMID: 37935198
4
PSMD14 stabilizes PKM2 through deubiquitination and activates PINK1-mediated mitophagy
PMID: 40000916
5
PSMD14 stabilizes SLC7A11 to suppress osteocyte ferroptosis in glucocorticoid-induced osteoporosis
PMID: 40444470
6
PSMD14 stabilizes LDHA leading to histone lactylation and enhanced lipid synthesis in pancreatic cancer
PMID: 41051446
7
PSMD14 stabilizes SF3B4 to promote alternative splicing in triple-negative breast cancer
PMID: 40344056
8
High PSMD14 expression correlates with poor prognosis across multiple cancer types
PMID: 39392083
Disease Associationsⓘ20
multiple myelomaOpen Targets
0.60Moderate
neoplasmOpen Targets
0.53Moderate
Mantle cell lymphomaOpen Targets
0.50Moderate
neurodegenerative diseaseOpen Targets
0.48Moderate
HIV infectionOpen Targets
0.48Moderate
amyloidosisOpen Targets
0.37Weak
lysosomal storage diseaseOpen Targets
0.32Weak
intelligenceOpen Targets
0.25Weak
mathematical abilityOpen Targets
0.17Weak
psoriasisOpen Targets
0.16Weak
non-small cell lung carcinomaOpen Targets
0.12Weak
cancerOpen Targets
0.12Weak
lymphomaOpen Targets
0.11Weak
breast cancerOpen Targets
0.11Weak
Waldenstrom macroglobulinemiaOpen Targets
0.11Weak
non-Hodgkins lymphomaOpen Targets
0.11Weak
hepatocellular carcinomaOpen Targets
0.11Weak
lung adenocarcinomaOpen Targets
0.11Weak
acute myeloid leukemiaOpen Targets
0.11Weak
osteosarcomaOpen Targets
0.10Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets5
BORTEZOMIB D-MANNITOLApproved
26S proteasome inhibitor
Mantle cell lymphoma
CARFILZOMIBApproved
26S proteasome inhibitor
multiple myeloma
IXAZOMIBApproved
26S proteasome inhibitor
multiple myeloma
IXAZOMIB CITRATEApproved
26S proteasome inhibitor
multiple myeloma
OPROZOMIBPhase II
26S proteasome inhibitor
Hodgkins lymphoma
Related Genes
MTORProtein interaction100%PRNPProtein interaction100%PSMA1Protein interaction100%PSMA2Protein interaction100%PSMA3Protein interaction100%PSMA4Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Heart
75%
Bone Marrow
57%
Liver
51%
Lung
43%
Ovary
20%
Gene Interaction Network
Click a node to explore
PSMD14MTORPRNPPSMA1PSMA2PSMA3PSMA4
PROTEIN STRUCTURE
Preparing viewer…
PDB8USB · 2.73 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.37Moderately Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.14 [0.07–0.37]
RankingsWhere PSMD14 stands among ~20K protein-coding genes
  • #1,629of 20,598
    Most Researched241 · top 10%
  • #389of 1,025
    FDA-Approved Drug Targets4
  • #1,745of 17,882
    Most Constrained (LOEUF)0.37 · top 10%
Genes detectedPSMD14
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
PMID: 37935198
Mol Cell · 2023
1.00
2
Histone lactylation stimulated upregulation of PSMD14 alleviates neuron PANoptosis through deubiquitinating PKM2 to activate PINK1-mediated mitophagy after traumatic brain injury.
PMID: 40000916
Autophagy · 2025
0.90
3
Structural insights into the ubiquitin-independent midnolin-proteasome pathway.
PMID: 40339123
Proc Natl Acad Sci U S A · 2025
0.80
4
PSMD14-mediated PFKFB2 deubiquitination activates H3K27 lactylation to drive cancer stemness in gastric adenocarcinoma.
PMID: 41193870
Cell Death Differ · 2026
0.76
5
Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m
PMID: 40344056
Sci Adv · 2025
0.70